CHEY HERMAN: Open Payments
NPI 1811514839 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,466 in 72 payments from 11 companies in 2025. Trend: 2023 $1,157 · 2024 $1,007 · 2025 $1,466
Food & beverage: $1,466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $380 |
| Novo Nordisk Inc | 17 | $329 |
| PFIZER INC. | 9 | $180 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| Lilly USA, LLC | 8 | $125 |
| Astellas Pharma US Inc | 4 | $78 |
| Amgen Inc. | 4 | $73 |
| Exact Sciences Corporation | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, Wegovy, MOUNJARO, NURTEC ODT, QULIPTA, Ozempic, Veozah, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
